Detalhe da pesquisa
1.
Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?
BMC Cancer
; 19(1): 28, 2019 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30621630
2.
Ramucirumab plus paclitaxel or FOLFIRI in platinum-refractory advanced or metastatic gastric or gastroesophageal junction adenocarcinoma-experience at two centres.
J Gastrointest Oncol
; 11(2): 366-375, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32399277